CIK 0001446847 · Accelerated filer<br>Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043404176
- Phone
- 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- 4 Open-market sale Chief Executive Officer sold 19,959 shares at $11.58 ($231,125)
- 4 Grant or award Director acquired 1,222 shares (grant or award)
- 4 Open-market sale Director sold 7,610 shares at $11.65 ($88,657)
- 4 Open-market sale Director sold 190,383 shares at $12.01 ($2,286,500)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Grant or award Director acquired 21,571 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 36,308 shares at $11.50 ($417,542)
- 4 Open-market sale Principal Accounting Officer sold 120 shares at $11.50 ($1,380)
- 4 Open-market sale CMO,SVP,Head-Res&Drug sold 10,583 shares at $11.50 ($121,705)
- 4 Open-market sale SVP, Chief Operating Officer sold 13,537 shares at $11.50 ($155,676)
- 4 Open-market sale Principal Accounting Officer sold 3,031 shares at $12.75 ($38,645)
- 4 Grant or award Director acquired 1,152 shares (grant or award)
- 4 Grant or award Director acquired 1,466 shares (grant or award)
Page 9 of 41 · 806 filings